Acorda Therapeutics
- Categories: Biotechnology, Pharmaceutical
- Client: Acorda Therapeutics
Another Key Placement by The Chase Group
Dr. Eliel Bayever Joins OncoQuest as Chief Medical Officer. We are so proud to connect life-changing executives and companies!
The Chase Group Successfully Completes Vice President, Clinical Development, Respiratory for Ionis Pharmaceuticals
The Chase Group appreciates and values our continued partnership with Ionis Pharmaceuticals and is pleased to announce the successful completion of the Vice President, Clinical…
Corporate Communications Executive Secured for Ipsen Biopharmaceuticals
The Chase Group, Inc. is pleased to announce the successful completion of a search for a Vice President of Internal and External Communications for Ipsen…
Esperion Therapeutics Taps The Chase Group to Fill Newly Created Role
Esperion Therapeutics has retained The Chase Group, Inc. to secure an Executive Director, Project Management. This newly created key leadership position will elevate internal collaboration…-
Vice President of Drug Safety for Ionis Pharmaceuticals Secured
The Chase Group announces another successful leadership recruitment with the placement of the Vice President of Drug Safety at Ionis Pharmaceuticals. Ionis is the leading… -
Ionis Engages The Chase Group to Continue Building QA Team
Ionis Pharmaceuticals has retained The Chase Group, Inc. to help build their GCP QA team. This dynamic role requires demonstrated expertise in GCP QA/QC with…